We are excited to announce that Jane Wasman, JD, has been appointed Athersys Board Chair. Read more here: buff.ly/3F2IxB0

Tomorrow is our Annual Meeting of Stockholders. The meeting will begin at 8:30 a.m. ET. If you're a stockholder, please have your control number ready. Both stockholders and guests can join 15 minutes prior to the start of the meeting here: virtualshareholdermeeting.co…

The American Stroke Association has a number of great resources for stroke patients and caregivers, including a directory of local support groups. Find the support group nearest to you here: buff.ly/3LzV7LP

Following major injuries or systemic infections, the immune system may react in a harmful manner. Factors expressed by MultiStem cells have the potential to deliver therapeutic benefit in several ways, such as reducing acute inflammation while also promoting tissue repair. #ATHXfacts

Reminder: The interim analysis of the MASTERS-2 trial will determine whether the current proposed study size is still sufficiently powered to achieve statistical significance following the change in primary endpoint. We expect these results to be available in October. #MultiStem #celltherapy #clinicaltrials

Today we remember and honor all those affected by the events of 9/11.

We wish Sarah a great day at Massachusetts General Hospital as she speaks to their Department of Neurology on MultiStem Cell Therapy for the Treatment of Acute Neurological Indications! #MultiStem #CellTherapy #Neurology

On September 8th, Dr. Sarah Busch, Vice President of Regenerative Medicine and Head of Business Development, will be giving a seminar to Massachusetts General Hospital's Department of Neurology.

Our most advanced clinical program at Athersys is the MASTERS-2 Study, a Phase 3 trial for the treatment of acute ischemic #stroke. Learn how #MultiStem interacts with the human body when administered intravenously following a stroke. youtu.be/DxAUBEImf-k?si=3v3A…

ICYMI: We are hosting a business update conference call this Wednesday, August 9, at 4:30 p.m. ET. Register in advance here: conferencingportals.com/even…

Leslie tells her story of having a major stroke at the age of 33 and speaks to how important it is to know the signs and symptoms. #strokeawareness youtu.be/6xWgpjRAzmI

We hope everyone has great day!

Today is the last day of #StrokeMonth. Stroke is a leading cause of death + serious disability around the world + knowing the signs can save lives. At Athersys, we remain committed to improving the quality of life for acute stroke survivors through #MultiStem. #StrokeAwareness